Login
$NEPH
$3.01 -$0.04 (1.31%) Live

$NEPH SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Spandow Oliver J., Director

Received 3,916 shares as a grant or award

12 Nov 2026 Form 4: Amron Arthur H, Director

Received 3,514 shares as a grant or award

05 Nov 2026 8-K: Results of Operations and Financial Condition

Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202

05 Nov 2026 10-Q
14 Oct 2026 Proxy statement: annual meeting on October 12, 2026

CEO pay $627K, up 53% · say-on-pay vote

13 Oct 2026 8-K: Shareholder Director Nominations; Other Events

Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202

16 Sep 2026 SCHEDULE 13D/A
16 Sep 2026 SCHEDULE 13G
16 Sep 2026 Form 4: Wexford Capital Lp, 10% owner and 3 others

Disposed of 3,377,821 shares (Other Transaction)

16 Sep 2026 Form 4: Amron Arthur H, Director and 1 other

Acquired 43,295 shares (Other Transaction)

20 Aug 2026 Form 4: Wexford Capital Lp, 10% owner and 3 others

Received 812 shares by exercise or conversion ($2.92K)

14 Aug 2026 Form 4: Amron Arthur H, Director

Received 2,418 shares as a grant or award

10 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 Call: 201 343 5202

12 Jun 2026 Form 4: Amron Arthur H, Director

Received 3,574 shares as a grant or award

15 Jun 2026 8-K: Regulation FD Disclosure

On June 12, 2026, Nephros, Inc. (the “Company”) posted an updated 2026 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1.

07 May 2026 8-K: Results of Operations and Financial Condition

Nephros Announces Financial Results for Quarter Ended March 31, 2026

07 May 2026 10-Q
30 Apr 2026 10-K/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support